Manufacturing News of Note—Biocon Bengaluru plant gets FDA nod; Samsung, Ichnos Sciences expand agreement

stocks
(Pixabay)

> The FDA has issued an Establishment Inspection Report concluding its investigation of Biocon’s biosimilar plant in Bengaluru, India. Filing (PDF)

> Samsung Biologics has won a long-term manufacturing agreement to produce a treatment for moderate-to-severe atopic dermatitis from Ichnos Sciences if it is approved. Release

> Pharma Logistics has acquired the pharma returns business of competitor Stericycle. Release

> Heraeus Pharmaceutical Ingredients is adding capacity to its plant in Hanau, Germany, to make platinum-based HPAPIs used in cancer chemotherapies Story

> Ingredient distributor Barentz has acquired a majority shareholding in ingredient maker IMCoPharma, which is based in Czech Republic. Release

Suggested Articles

Merck KGaA could see billions of dollars in revenue opportunity as it assists certain players with their COVID-19 scale-up, an analyst says. 

Some pharma executives have been predicting a COVID-19 vaccine debut by year's end, but Merck CEO Kenneth Frazier doubts that's possible.

BARDA has updated its contract with Emergent BioSolutions to lock down extra doses of the company's up-and-coming anthrax shot, NuThrax.